Back to Results
First PageMeta Content
Ethics / Office of Inspector General / U.S. Department of Health and Human Services / United States Department of Health and Human Services / Chief compliance officer / Inspector General / Aggregate Spend / Business ethics / Frank E. Sheeder III / Regulatory compliance / Corporate governance / Applied ethics


DECLARATION OF COMPLIANCE AND DESCRIPTION OF COMPLIANCE PROGRAM Introduction Our ambition is to continue as a strong, growing and innovative business long into the future. Our business values are performance, innovation
Add to Reading List

Document Date: 2014-04-30 12:09:23

Open Document

File Size: 163,64 KB

Share Result on Facebook

City

Memphis / Fort Worth / St. Petersburg / /

Company

I. Introduction Smith & Nephew Inc. / Healthpoint Biotherapeutics / Smith & Nephew Inc. / EthicsPoint / /

Country

United States / /

Currency

USD / /

Event

M&A / /

IndustryTerm

medical device manufacturer / pharmaceutical industry / law makes / legitimate professional healthcare services / pharmaceutical products / healthcare professional / /

Movie

Page 3 5 / /

Organization

U.S. Department of Health and Human Services / office of Inspector General / Compliance Committee / Advanced Surgical Devices Division / Group Ethics & Compliance Committee / U.S. Securities and Exchange Commission / Division Compliance Committee / Wound Management Division / /

/

Position

CEO / Compliance Officer / Chief Compliance Officer / Chief Legal Officer and Chief Financial Officer / senior level officer / /

Product

AdvaMed Code / /

ProvinceOrState

Texas / Florida / California / Massachusetts / /

URL

www.ethicspoint.com / /

SocialTag